ロード中...
Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS)
BACKGROUND AND OBJECTIVE: Treatment with proton pump inhibitors (PPIs) has been associated with development of hepatic encephalopathy (HE). As development of HE is a major complication after implantation of a transjugular intrahepatic portosystemic shunt (TIPS), we hypothesized that PPI treatment ma...
保存先:
| 出版年: | United European Gastroenterol J |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6206537/ https://ncbi.nlm.nih.gov/pubmed/30386611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640618795928 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|